Life Saving Drugs Program – MPS I – Review summary and expert panel recommendations for consumers

This MPS I review considered laronidase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.


Life Saving Drugs Program – MPS I – Medicines review summary for consumers

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
General public

Help us improve

If you would like a response please use the enquiries form instead.